GSK (LON:GSK) Given “Underweight” Rating at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their underweight rating on shares of GSK (LON:GSK) in a research report sent to investors on Tuesday morning, MarketBeat reports.

A number of other equities analysts also recently commented on the stock. Deutsche Bank Aktiengesellschaft restated a buy rating and issued a GBX 1,950 ($24.66) target price on shares of GSK in a research note on Friday, June 28th. Barclays restated an equal weight rating and set a GBX 1,725 ($21.82) price objective on shares of GSK in a report on Tuesday, May 7th. Citigroup reiterated a buy rating and issued a GBX 2,100 ($26.56) target price on shares of GSK in a report on Monday, June 24th. Shore Capital restated a buy rating on shares of GSK in a report on Thursday, June 27th. Finally, Jefferies Financial Group reiterated a buy rating and set a GBX 2,100 ($26.56) target price on shares of GSK in a report on Thursday, June 27th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, GSK currently has a consensus rating of Moderate Buy and an average price target of GBX 1,791.25 ($22.66).

GSK Trading Down 0.0 %

LON GSK opened at GBX 1,503.15 ($19.01) on Tuesday. The stock has a market cap of £61.33 billion, a PE ratio of 1,379.36, a PEG ratio of 1.19 and a beta of 0.27. GSK has a 12 month low of GBX 1,302.60 ($16.48) and a 12 month high of GBX 1,823.50 ($23.06). The company’s 50-day moving average price is GBX 1,683.57 and its 200-day moving average price is GBX 1,632.74. The company has a current ratio of 0.87, a quick ratio of 0.73 and a debt-to-equity ratio of 134.34.

GSK Cuts Dividend

The business also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be paid a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

Insiders Place Their Bets

In other news, insider Wendy Becker bought 446 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The stock was bought at an average price of GBX 1,614 ($20.41) per share, with a total value of £7,198.44 ($9,105.03). 1.60% of the stock is currently owned by corporate insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.